Minister of Science Technology and Innovation, Adeleke Mamora, has announced that his ministry has developed sickle cell and venom vaccines.
Speaking on Monday, December 12, at the 10th edition of the PMB Administration Scorecard Series (2015-2023), Mamora said the ministry achieved the use of local herbs for the production of drugs for sickle cell as the country had a high number of people with sickle cell anaemia.
Also announcing some of the achievements of his ministry, Mamora added;
“There is also the development of an anti-venom vaccine, an anti-penic that reduces fat in the body.
“The Ministry, through Raw Materials Research and Development Council’s programme on development of the dairy sector, introduced the technology of increasing daily milk yield from our cows from 1-1.5 litres of milk per cow to over 15 litres per cow in a day.
“The National Space Research and Development Agency is working to establish a Space Museum and Planetarium that is expected to realise about N30 billion, boost tourism activities, provide 5000 direct jobs; 20,000 indirect jobs and improve the teaching of STI.
“Our future is full of optimism as long as we keep faith and leverage on the enormous power of STI coupled with demand-driven R&D programmes and projects.
“The fourth industrial revolution will register Nigeria’s presence and effective participation if we sustain and escalate current commitment and interest in research and innovation as principal push factors for technological advancement.
“We need courage, discipline and focus on fundamental principles of the culture of result-based management logical framework where all policy implementation efforts will produce outcomes.”
Post a Comment
Disclaimer!!! Opinions expressed in comments do not represent THE FOREFRONT MEDIA NG's views. All participants are entitled to their opinions. Thank you!!!
Advertise on the Forefront: For advert placement in the blog or advert posts like news updates, reach +2348124620827 [WhatsApp].
Copyright 2022 The Forefront Media Ng. All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from The Forefront Media Ng